FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 2941554 · Received February 4, 2013

Report

Report Number
2124215-2013-02392
Event Type
Injury
Date Received
February 4, 2013
Date of Event
October 19, 2012
Report Date
November 2, 2012
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
PMA / PMN Number
P910073
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PATIENT FAMILY MEMBER OR FRIEND

Narratives

Additional Manufacturer Narrative · 1

THE LOCAL AREA SALES REPRESENTATIVE WAS CONTACTED FOR ADDITIONAL INFORMATION REGARDING THE INFECTION HOWEVER NONE WAS PROVIDED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS REPORT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS PRODUCT DEVELOPED AN INFECTION AT THE DEVICE SITE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
47255 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0185

Patients

Seq Age Sex Outcome Treatment
1 89 YR Life Threatening 0185| E102